DNA financials
Ginkgo (DNA) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
DNA income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $170.16M | $138.63M | -$315.28M | -$312.76M | -5.64 |
| 2024 | $227.04M | $188.49M | -$559.76M | -$547.03M | -10.54 |
| 2023 | $251.46M | $197.45M | -$864.41M | -$892.87M | -18.40 |
| 2022 | $477.71M | $273.49M | -$2.21B | -$2.10B | -50.20 |
| 2021 | $313.84M | $184.15M | -$1.83B | -$1.83B | -55.53 |
| 2020 | $76.66M | $61.05M | -$137.03M | -$126.61M | -4.00 |
- DNA revenue was $170.16M in fiscal 2025, net income -$312.76M.
Updated 2026-11-07 11:53 UTC